Anthem Biosciences Limited (ANTHEM) reported revenue of ₹418 Cr and net profit of ₹120 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
ANTHEM fundamentals, Fundamental score 95/100
The statements below are read from Anthem Biosciences Limited’s filed results, 9 filed quarters and 7 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Jul 22, 2026 · audited
Sales CAGR · 3Y+26.2%FY22 → FY25
Sales CAGR · 4Y+14.6%FY21 → FY25
PAT CAGR · 3Y+15.4%FY22 → FY25
PAT CAGR · 4Y+9.9%FY21 → FY25
Price · 1Y+10.7%EOD
Price CAGR · 3Y—EOD
Quarterly resultsConsolidated
₹ Cr
Jun2024
Sep2024
Dec2024
Mar2025
Jun2025
Sep2025
Dec2025
Mar2026
Jun2026Latest
YoYlatest
Sales
339
525
498
483
540
550
423
611
418
-22.6%
218
330
338
288
349
332
266
344
268
-23.2%
Operating profit
121
195
160
195
191
218
157
267
151
-21.4%
OPM %
35.7%
37.1%
32.1%
40.4%
35.4%
39.6%
37.1%
43.7%
36.0%
+0.6 pp
Other income
19.0
28.0
24.0
14.0
22.8
48.2
33.5
51.2
24.9
+9.1%
Interest
4.00
4.00
3.00
1.00
1.61
3.03
0.35
1.90
0.89
-44.9%
Depreciation
19.0
20.0
20.0
30.0
26.4
33.5
34.5
39.6
30.0
+13.4%
Profit before tax
118
200
161
178
186
230
130
278
145
-22.4%
Tax %
30.5%
19.0%
23.0%
—
27.1%
24.5%
28.9%
31.7%
17.0%
-10.0 pp
Net profit
82.0
162
124
83.0
136
173
92.8
190
120
-11.7%
EPS (₹)
1.47
2.90
2.22
1.48
2.43
3.09
1.65
0.00
2.13
-12.3%
One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split↔ scroll for earlier quarters
Revenue & net profit trend
last 9 quarters
RevenueNet profit
Revenue & net profit — Consolidated9 quarters
Segment results
Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.
Forensic checksauto-scanned from the filing
Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.
How results moved the priceEOD reaction on the session the market could trade the filing
Avg absolute result-day move ±3.2%· EPS surprise: no estimates source· 4 earlier quarters have no dated filing on record
